Pfizer, BioNTech begin rolling submission for EUA for COVID vaccine kids below 5 Ruchika Sharma2 Feb 2022 2:09 PM ISTThis application is for authorization of the first two 3 g doses of a planned three-dose primary series in age group of 6 months to 5 years
Pfizer, Ionis Pharma discontinue Vupanorsen Clinical Development Program Ruchika Sharma2 Feb 2022 2:01 PM ISTNew York: Pfizer Inc. and Ionis Pharmaceuticals, Inc. have recently announced the discontinuation of the Pfizer-led clinical development...
Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Pfizer COVID pill for high-risk patients get EU drug regulator nod Ruchika Sharma30 Jan 2022 9:45 AM ISTNew Delhi: The European Union's drug regulator on Thursday gave the green light to Pfizer Inc's antiviral COVID-19 pill for treating adults at...
Moderna begins trial of Omicron-specific COVID vaccine booster MD Bureau29 Jan 2022 9:00 AM ISTNew York: US drug maker Moderna has started trial of a Covid booster vaccine that specifically targets the Omicron variant, the company has announced....
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
Fate of Pfizer COVID pill Paxlovid to be decided by EU regulator by January end: Report Ruchika Sharma26 Jan 2022 9:30 AM ISTBrussels: The European Union's drug regulator is set to decide whether to approve Pfizer's Covid-19 pill at the end of this month, before a final...
Covid-19: Pfizer, CornoaVac vaccine linked to heart inflammation risk in adolescents MD Bureau25 Jan 2022 3:54 PM ISTHong Kong: Despite low absolute risk, there is an increased relative risk of carditis -- a type of heart inflammation -- associated with Covid vaccine...
Pfizer-OPKO growth hormone deficiency treatment rejected by USFDA Farhat Nasim24 Jan 2022 6:34 PM ISTAn approval would have allowed Pfizer to compete with Ascendis Pharma (A71.F), whose once weekly growth hormone injectable was approved by the FDA in...
Moderna vax may lead to fewer breakthrough Covid infections than Pfizer: study Medical Dialogues Bureau23 Jan 2022 1:00 PM ISTThe research, published in the Journal of the American Medical Association, also found those who received the Moderna vaccine were less likely to be...
Pfizer chief granted USD 1 million Genesis Prize for development of COVID-19 vaccine Dr. Divya Colin21 Jan 2022 9:30 AM ISTPfizer's vaccine was the first to win U.S. approval for emergency use in December 2020, and Israel quickly became one of the first countries to...
